Active Shortage

ROCURONIUM BROMIDE INJECTION

JUNO PHARMA CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ROCURONIUM BROMIDE INJECTION in Canada?

Yes. ROCURONIUM BROMIDE INJECTION 10MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is ROCURONIUM BROMIDE INJECTION not available?

The reason the manufacturer reported: Demand increase for the drug.

When will ROCURONIUM BROMIDE INJECTION be available again?

The manufacturer's estimated resolution date is March 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~4 months remaining (estimate)

Affected strength10MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ROCURONIUM BROMIDE INJECTION

SANDOZ CANADA INCORPORATED

10MG · DIN 02318415

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

EUGIA-ROCURONIUM BROMIDE INJECTION

EUGIA PHARMA INC.

10MG · DIN 02498820

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-03-15

~4 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02469774

Strength

10MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ROCURONIUM BROMIDE

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

ROCURONIUM BROMIDE INJECTION has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Resolved

Demand increase for the drug.

Other Products from JUNO PHARMA CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ARGATROBAN FOR INJECTION

100MG · DIN 02561557

BIMATOPROST RC

0.01% · DIN 02529580

CALCIUM CHLORIDE INJECTION USP

100MG · DIN 00821780

CARBETOCIN INJECTION

100MCG · DIN 02489244

CARBOPROST TROMETHAMINE INJECTION USP

250MCG · DIN 02538377

CASPOFUNGIN FOR INJECTION

50MG · DIN 02460947